About Reagene Biosciences
Reagene Biosciences is a Healthcare company based in Bengaluru (India) founded in 2016. Provider of research reagents and kits. Reagene Biosciences has raised $70.13 thousand across 2 funding rounds from investors including Suresh Poosala, Aruna Bayya and Dhanashri Girish Gudi. Reagene Biosciences was last valued at $245.16 thousand in February 2020. Its Indian entity Reagene Biosciences Private Limited reported revenue of ₹17.5 Lakh. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified.
Company details
Reagene Biosciences provides reagents for biochemistry, molecular biology, and cell cultures. The company has developed the platforms ReaGene Discovery Platform, ReaSkin, ReaADME (in vitro human assay), ReaPath(3D printed tissue for research), and ReaLite (assay and lab support). The ReaGEn, an FDA approved platform, offers translational 3D cell-based assays for drug discovery prior to animal studies.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website reagenebiosciences.com
- Social Facebook
- Legal Name Reagene Biosciences Private Limited
- Date of Incorporation 01 Sep, 2016
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹17.5 Lakh
FY 2023 · -1% YoY
- Net Loss-₹14.4 Lakh
FY 2023 · -82% margin
- EBITDA-₹12.4 Lakh
FY 2023 · -71% margin
- Total Equity Funding$70.13K (USD)
in 2 rounds
- Latest Funding Round$51.62K (USD), Angel Round
Feb 2020
Associated legal entities of Reagene Biosciences
Reagene Biosciences operates through Reagene Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Reagene Biosciences Private Limited CIN U24299KA2016PTC096198 | Active | 01 Sep 2016 | Bengaluru, Karnataka | ₹0.2 Cr | 2 | View details |
Funding Insights of Reagene Biosciences
Reagene Biosciences has successfully raised a total of $70.13K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $51.62 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $70,130
- Total Rounds 2
- Last Round Angel Round — $51,621
- First Round $18,509
(Mar 2018)
- Investors Count 3
All 2 funding rounds of Reagene Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $51,621 | Angel Round | $245,157 | Suresh Poosala | |
| Mar 2018 | $18,509 | Angel Round | $92,064 | Aruna Bayya |
Last known valuation $245,157 (Feb 2020). 3 investors in total: 0 institutional and 3 angel.
Investors in Reagene Biosciences
Reagene Biosciences has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Suresh Poosala, Aruna Bayya and Dhanashri Girish Gudi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SP Suresh Poosala | Founder of Zluri, SaaS management platform, and active angel investor | unknown_f3a997b9a69b40bd9 | ||
AB Aruna Bayya | unknown_5d2ba5ecfbb64c939 | |||
DG Dhanashri Girish Gudi | unknown_a1084a99964646f4a |
Investor details for Reagene Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Reagene Biosciences Private Limited (Reagene Biosciences)
Reagene Biosciences Private Limited is the primary company behind Reagene Biosciences. The board of Reagene Biosciences Private Limited currently have 2 directors; the longest-serving is Prema Kolachana, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prema Kolachana DIN 07547950 | Managing Director | 01 Sep 2016 | 10 yrs 2 mo | Reagene Biosciences Private Limited |
| Nishant Nemani Dhamnekar DIN 08418450 | Director | 10 Apr 2019 | 7 yrs 7 mo | Reagene Biosciences Private Limited |
Financials of Reagene Biosciences
Figures of Reagene Biosciences Private Limited, the primary company behind Reagene Biosciences, for FY 2023. Revenue was ₹17.5 Lakh (-1% year on year). Net loss was -₹14.4 Lakh (-82% margin). EBITDA was -₹12.4 Lakh (-71% margin). Revenue has grown at a compounded annual rate of +30% over three years and +124% over five years.
- ₹17.5 LakhRevenue · FY 2023 · -1% YoY
- -₹14.4 LakhNet loss · -82% margin
- -₹12.4 LakhEBITDA · -71% margin
- ₹1.10 CrPaid-up capital
- +30%Revenue CAGR, 3 years
- +124%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Reagene Biosciences Private Limited are on its company page.
Detailed financial statements for Reagene Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Reagene Biosciences
3 dated milestones of Reagene Biosciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Reagene Biosciences is founded.
- Funding First funding round of $19K.
- Funding Latest funding round, Angel Round, of $52K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reagene Biosciences
Complete news archive for Reagene Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reagene Biosciences
Reagene Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Reagene Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Reagene Biosciences is a funded company, having raised a total of $70.13K across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $18.51K, raised on Mar 2018.
The primary company behind Reagene Biosciences, Reagene Biosciences Private Limited, reported revenue of ₹17.5 Lakh for FY 2023, down 1% year on year.
Reagene Biosciences provides reagents for biochemistry, molecular biology, and cell cultures. The company has developed the platforms ReaGene Discovery Platform, ReaSkin, ReaADME (in vitro human assay), ReaPath(3D printed tissue for research), and ReaLite (assay and lab support). The ReaGEn, an FDA approved platform, offers translational 3D cell-based assays for drug discovery prior to animal studies.
Reagene Biosciences has 3 investors. Key investors include Suresh Poosala, Aruna Bayya, and Dhanashri Girish Gudi.
The valuation of Reagene Biosciences is $245.16K as of Feb 2020.
Reagene Biosciences operates through Reagene Biosciences Private Limited.
The legal entities of Reagene Biosciences currently have 2 directors, including Prema Kolachana, Nishant Nemani Dhamnekar.